The findings revealed S100A8/A9 as an independent predictor of subsequent HF, even after adjusting for traditional risk factors, such as infarct size, classic inflammatory biomarkers, and systolic ventricular performance, highlighting its potential value as a prognostic tool for patients with HF (26). This evidence concerns the gene S100A8 and hydrops fetalis.